• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤微环境中TNF-α和NF-κB的高表达预示着BCLC-0-B期肝细胞癌患者的良好预后。

The high expression of TNF-α and NF-κB in tumor microenvironment predicts good prognosis of patients with BCLC-0-B hepatocellular carcinoma.

作者信息

Li Haoran, Wang Yanhua, Zhang Mao, Hu Jie, Li Zixiang, Han Bing

机构信息

Department of Hepatobiliary and Pancreatic Surgery, The Affiliated Hospital of Qingdao University, Qingdao 266005, China.

Interventioanl Medicine Center, The Affiliated Hospital of Qingdao University, Qingdao 266005, China.

出版信息

Transl Cancer Res. 2019 Apr;8(2):532-541. doi: 10.21037/tcr.2019.03.09.

DOI:10.21037/tcr.2019.03.09
PMID:35116785
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8799116/
Abstract

BACKGROUND

In hepatocellular carcinoma (HCC), inflammatory factors play an important role, but their effects on the prognosis of patients with HCC are still not very clear.

METHODS

Immunohistochemical staining was used to detect the expression of tumor necrosis factor-alpha (TNF-α) and nuclear factor-kappa B (NF-κB) in tumour tissues of Barcelona Clinic Liver Cancer-0-B stage (BCLC-0-B) patients with HCC. The relationship between TNF-α and NF-κB expression and clinicopathological features was analysed by χ test. Kaplan-Meier analysis and the log-rank test were used to compare the prognoses of TNF-α and NF-κB high and low-expression groups among HCC patients. The Cox proportional hazard model was used to analyse HCC prognosis by univariate and multivariate analysis.

RESULTS

Patients with HCC had significantly longer survival times in the TNF-α/NF-κB high-coexpression group (P<0.05). High expression of TNF-α and NF-κB is an independent prognostic factor predicting postoperative survival and recurrence in patients with HCC (P<0.05).

CONCLUSIONS

High expression of TNF-α and NF-κB in the HCC microenvironment can predict survival, and patients with high expression have longer survival times and slowing the recurrence time than those in the low-expression group.

摘要

背景

在肝细胞癌(HCC)中,炎症因子发挥着重要作用,但其对HCC患者预后的影响仍不太明确。

方法

采用免疫组织化学染色法检测巴塞罗那临床肝癌0 - B期(BCLC - 0 - B)HCC患者肿瘤组织中肿瘤坏死因子-α(TNF-α)和核因子-κB(NF-κB)的表达。通过χ检验分析TNF-α和NF-κB表达与临床病理特征之间的关系。采用Kaplan-Meier分析和对数秩检验比较HCC患者中TNF-α和NF-κB高表达组与低表达组的预后。采用Cox比例风险模型对HCC预后进行单因素和多因素分析。

结果

TNF-α/NF-κB高共表达组的HCC患者生存时间显著更长(P<0.05)。TNF-α和NF-κB高表达是预测HCC患者术后生存和复发的独立预后因素(P<0.05)。

结论

HCC微环境中TNF-α和NF-κB高表达可预测生存,高表达患者比低表达组患者生存时间更长且复发时间延缓。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/087b/8799116/42bb420063de/tcr-08-02-532-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/087b/8799116/354e14699f37/tcr-08-02-532-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/087b/8799116/7b35293b03fe/tcr-08-02-532-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/087b/8799116/267db7921725/tcr-08-02-532-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/087b/8799116/da26c08e36c4/tcr-08-02-532-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/087b/8799116/42bb420063de/tcr-08-02-532-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/087b/8799116/354e14699f37/tcr-08-02-532-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/087b/8799116/7b35293b03fe/tcr-08-02-532-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/087b/8799116/267db7921725/tcr-08-02-532-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/087b/8799116/da26c08e36c4/tcr-08-02-532-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/087b/8799116/42bb420063de/tcr-08-02-532-f5.jpg

相似文献

1
The high expression of TNF-α and NF-κB in tumor microenvironment predicts good prognosis of patients with BCLC-0-B hepatocellular carcinoma.肿瘤微环境中TNF-α和NF-κB的高表达预示着BCLC-0-B期肝细胞癌患者的良好预后。
Transl Cancer Res. 2019 Apr;8(2):532-541. doi: 10.21037/tcr.2019.03.09.
2
[Expression characteristics of nuclear factor kappa B in hepatocellular carcinoma tissues].[核因子κB在肝癌组织中的表达特征]
Zhonghua Gan Zang Bing Za Zhi. 2009 Nov;17(11):843-6.
3
High expression of protein phosphatase 2 regulatory subunit B'' alpha predicts poor outcome in hepatocellular carcinoma patients after liver transplantation.蛋白磷酸酶2调节亚基B''α的高表达预示着肝细胞癌患者肝移植后的不良预后。
World J Gastrointest Oncol. 2021 Jul 15;13(7):716-731. doi: 10.4251/wjgo.v13.i7.716.
4
High TNF-α and/or p38MAPK expression predicts a favourable prognosis in patients with TNM hepatocellular carcinoma: An immunohistochemical study.高肿瘤坏死因子-α(TNF-α)和/或p38丝裂原活化蛋白激酶(p38MAPK)表达预示TNM分期肝细胞癌患者预后良好:一项免疫组织化学研究
Oncol Lett. 2019 Jun;17(6):4948-4956. doi: 10.3892/ol.2019.10193. Epub 2019 Mar 27.
5
EYA4 inhibits hepatocellular carcinoma growth and invasion by suppressing NF-κB-dependent RAP1 transactivation.EYA4 通过抑制 NF-κB 依赖的 RAP1 反式激活来抑制肝癌的生长和侵袭。
Cancer Commun (Lond). 2018 Apr 3;38(1):9. doi: 10.1186/s40880-018-0276-1.
6
High expression of Snail and NF-κB predicts poor survival in Chinese hepatocellular carcinoma patients.Snail和NF-κB的高表达预示着中国肝细胞癌患者的预后不良。
Oncotarget. 2017 Jan 17;8(3):4543-4548. doi: 10.18632/oncotarget.13891.
7
A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.一种在肝细胞癌中上调的新型预后生物标志物SPC24。
Oncotarget. 2015 Dec 1;6(38):41383-97. doi: 10.18632/oncotarget.5510.
8
Long-term use of indomethacin leads to poor prognoses through promoting the expression of PD-1 and PD-L2 via TRIF/NF-κB pathway and JAK/STAT3 pathway to inhibit TNF-α and IFN-γ in hepatocellular carcinoma.长期使用吲哚美辛通过TRIF/NF-κB途径和JAK/STAT3途径促进PD-1和PD-L2的表达,从而抑制肝细胞癌中的TNF-α和IFN-γ,导致预后不良。
Exp Cell Res. 2015 Sep 10;337(1):53-60. doi: 10.1016/j.yexcr.2015.07.007. Epub 2015 Jul 7.
9
Anti-inflammatory effect of pitavastatin on NF-kappaB activated by TNF-alpha in hepatocellular carcinoma cells.匹伐他汀对肿瘤坏死因子-α激活的肝癌细胞中核因子-κB的抗炎作用。
Biol Pharm Bull. 2006 Apr;29(4):634-9. doi: 10.1248/bpb.29.634.
10
Inhibition of nuclear factor-κB enhances the antitumor effect of tumor necrosis factor-α gene therapy for hepatocellular carcinoma in mice.核因子-κB 的抑制增强了肿瘤坏死因子-α基因治疗对小鼠肝癌的抗肿瘤作用。
Surgery. 2013 Sep;154(3):468-78. doi: 10.1016/j.surg.2013.05.037.

引用本文的文献

1
Tumor Necrosis Factor-Alpha and Adiponectin in Nonalcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma.非酒精性脂肪性肝病相关肝细胞癌中的肿瘤坏死因子-α与脂联素
Cancers (Basel). 2023 Nov 6;15(21):5306. doi: 10.3390/cancers15215306.
2
Dynamic Changes of Cytokine Profiles and Their Correlation With Tumor Recurrence Following Thermal Ablation in Hepatocellular Carcinoma.热消融治疗肝细胞癌后细胞因子谱的动态变化及其与肿瘤复发的相关性。
Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231190644. doi: 10.1177/15330338231190644.
3
Detection of sFas, sCD137, and IL-27 Cytokines as Potential Biomarkers for Hepatocellular Carcinoma Diagnosis.

本文引用的文献

1
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
2
Cyclooxygenase-2 expression is associated with elevated aspartate aminotransferase level in hepatocellular carcinoma.环氧化酶-2的表达与肝细胞癌中天冬氨酸转氨酶水平升高相关。
J Cancer Res Ther. 2015 Oct-Dec;11(4):786-92. doi: 10.4103/0973-1482.147692.
3
Cancer statistics in China, 2015.
检测sFas、sCD137和IL-27细胞因子作为肝细胞癌诊断的潜在生物标志物。
J Hepatocell Carcinoma. 2023 May 26;10:783-793. doi: 10.2147/JHC.S409649. eCollection 2023.
4
Specific S100 Proteins Bind Tumor Necrosis Factor and Inhibit Its Activity.特定的 S100 蛋白结合肿瘤坏死因子并抑制其活性。
Int J Mol Sci. 2022 Dec 15;23(24):15956. doi: 10.3390/ijms232415956.
5
Exosomal miR-29b from cancer-associated fibroblasts inhibits the migration and invasion of hepatocellular carcinoma cells.来自癌症相关成纤维细胞的外泌体miR-29b抑制肝癌细胞的迁移和侵袭。
Transl Cancer Res. 2020 Apr;9(4):2576-2587. doi: 10.21037/tcr.2020.02.68.
6
Inflammation induced by lipopolysaccharide advanced androgen receptor expression and epithelial-mesenchymal transition progress in prostatitis and prostate cancer.脂多糖诱导的炎症促进了前列腺炎和前列腺癌中雄激素受体的表达以及上皮-间质转化进程。
Transl Androl Urol. 2021 Nov;10(11):4275-4287. doi: 10.21037/tau-21-964.
7
Hyperion imaging system reveals heterogeneous tumor microenvironment of oral squamous cell carcinoma patients at T1N0M0 stage.海波龙成像系统揭示了T1N0M0期口腔鳞状细胞癌患者的肿瘤微环境异质性。
Ann Transl Med. 2020 Nov;8(22):1513. doi: 10.21037/atm-20-7194.
《中国癌症统计数据 2015》
CA Cancer J Clin. 2016 Mar-Apr;66(2):115-32. doi: 10.3322/caac.21338. Epub 2016 Jan 25.
4
Incidence of hepatocellular carcinoma reduced by phlebotomy treatment in patients with chronic hepatitis C.慢性丙型肝炎患者通过放血疗法治疗后肝细胞癌发病率降低。
Intern Med. 2015;54(2):107-17. doi: 10.2169/internalmedicine.54.2715. Epub 2015 Jan 15.
5
Chronic inflammation and cytokines in the tumor microenvironment.肿瘤微环境中的慢性炎症和细胞因子。
J Immunol Res. 2014;2014:149185. doi: 10.1155/2014/149185. Epub 2014 May 13.
6
Clinical aspects of tumor necrosis factor-α signaling in hepatocellular carcinoma.肝细胞癌中肿瘤坏死因子-α信号的临床方面。
Curr Pharm Des. 2014;20(17):2799-808. doi: 10.2174/13816128113199990587.
7
The inflammatory microenvironment in hepatocellular carcinoma: a pivotal role for tumor-associated macrophages.肝细胞癌中的炎症微环境:肿瘤相关巨噬细胞的关键作用。
Biomed Res Int. 2013;2013:187204. doi: 10.1155/2013/187204. Epub 2012 Dec 30.
8
Hepatocellular carcinoma risk prediction model for the general population: the predictive power of transaminases.人群肝细胞癌风险预测模型:转氨酶的预测能力。
J Natl Cancer Inst. 2012 Oct 17;104(20):1599-611. doi: 10.1093/jnci/djs372.
9
Effect of β-carotene on immunity function and tumour growth in hepatocellular carcinoma rats.β-胡萝卜素对肝癌大鼠免疫功能和肿瘤生长的影响。
Molecules. 2012 Jul 18;17(7):8595-603. doi: 10.3390/molecules17078595.
10
Risk factors of hepatocellular carcinoma--current status and perspectives.肝细胞癌的危险因素——现状与展望
Asian Pac J Cancer Prev. 2012;13(3):743-52. doi: 10.7314/apjcp.2012.13.3.743.